Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03169530 · ClinicalTrials.gov registry record · NA
Moderate Alcohol and Cardiovascular Health Trial
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT03169530 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 103 participants.
The verdict
NCT03169530, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
The Moderate Alcohol and Cardiovascular Health Trial (MACH15) is a multicenter, worldwide, randomized clinical trial of \~15 gm of alcohol daily versus abstention, using a balanced parallel design and single-blind assessment of all outcomes among approximately 7,800 participants aged 50 years and older with advanced cardiovascular risk. Intervention will average 6 years in duration with a common close-out date. Following recruitment and pre-screening, participants will attend a screening visit followed by a two-week abstention washout period, a baseline visit and randomization, and subsequent visits at 3 months, 6 months, 12 months, and then annually until close-out.
Interventions
- OTHER Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2018-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03169530
The ClinicalTrials.gov registry entry for NCT03169530 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcohol is the first listed.
NCT03169530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03169530 about?
NCT03169530 is a clinical study titled "Moderate Alcohol and Cardiovascular Health Trial". The Moderate Alcohol and Cardiovascular Health Trial (MACH15) is a multicenter, worldwide, randomized clinical trial of \~15 gm of alcohol daily versus abstention, using a balanced parallel design and single-blind assessment of all outcomes among approximately 7,800 participants aged 50 years and ol...
What is the current status of trial NCT03169530?
This trial is currently terminated. It is a NA study. The enrollment target is 103 participants. The study started on 2018-02-05. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT03169530?
The interventions under investigation include: Alcohol (OTHER).
Who is sponsoring clinical trial NCT03169530?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.